Vanguard Asset Management
BSX icon

Vanguard Asset Management’s Boston Scientific BSX Stock Holding History

Vanguard Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Buy
2,873,191
+306,096
+12% +$16.6M 0.08% 227
2026
Q1 		$161M Buy
+2,567,095
New +$205M 0.14% 139

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Asset Management's BSX Position: Q2 2026 in Review

Vanguard Asset Management increased its Boston Scientific (BSX) stake by 12% in Q2 2026, buying an estimated $16.6M and bringing the position to 2,873,191 shares worth $123M. The position accounts for 0.08% of the portfolio, ranked #227.

Vanguard Asset Management first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $161M in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanguard Asset Management held 2,873,191 shares of Boston Scientific worth $123M as of Q2 2026.
  • Vanguard Asset Management bought 306,096 Boston Scientific shares in Q2 2026, an estimated $16.6M.
  • Boston Scientific made up 0.08% of Vanguard Asset Management's portfolio in Q2 2026, its #227 holding.
  • Vanguard Asset Management first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Boston Scientific position peaked at $161M in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.